Brokerages Set Sotera Health Company (NASDAQ:SHC) Target Price at $20.43

Sotera Health Company (NASDAQ:SHC) has been assigned an average recommendation of “Moderate Buy” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $20.4286.

A number of analysts have commented on SHC shares. Piper Sandler upgraded shares of Sotera Health from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $17.00 to $24.00 in a research note on Friday, January 9th. Zacks Research lowered shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. Wells Fargo & Company cut shares of Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Royal Bank Of Canada began coverage on shares of Sotera Health in a research report on Thursday, January 8th. They set an “outperform” rating and a $24.00 target price for the company. Finally, Citigroup upped their target price on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th.

Insider Activity at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director owned 12,735,301 shares in the company, valued at $194,468,046.27. This trade represents a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 47.55% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Sotera Health

Institutional investors have recently bought and sold shares of the stock. Nordea Investment Management AB purchased a new stake in shares of Sotera Health in the fourth quarter valued at about $1,908,000. Exchange Traded Concepts LLC purchased a new position in Sotera Health during the fourth quarter worth about $7,739,000. Two Seas Capital LP boosted its holdings in Sotera Health by 21.1% during the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock worth $44,712,000 after purchasing an additional 699,731 shares during the last quarter. Hudson Bay Capital Management LP bought a new stake in Sotera Health in the 3rd quarter worth about $3,932,000. Finally, CenterBook Partners LP bought a new stake in Sotera Health in the 3rd quarter worth about $1,228,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $14.96 on Friday. The business has a 50-day simple moving average of $15.85 and a 200 day simple moving average of $16.53. Sotera Health has a one year low of $9.53 and a one year high of $19.85. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24. The firm has a market capitalization of $4.25 billion, a price-to-earnings ratio of 55.41 and a beta of 1.88.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.02. The business had revenue of $303.44 million for the quarter, compared to analyst estimates of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, research analysts anticipate that Sotera Health will post 0.61 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.